Sales rise 10.60% to Rs 87.11 crore
Net profit of Novartis India declined 13.81% to Rs 20.41 crore in the quarter ended September 2024 as against Rs 23.68 crore during the previous quarter ended September 2023. Sales rose 10.60% to Rs 87.11 crore in the quarter ended September 2024 as against Rs 78.76 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales87.1178.76 11 OPM %20.6321.47 -PBDT28.1533.08 -15 PBT27.5632.43 -15 NP20.4123.68 -14Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
